← Eichor
Study identifier: NCT04425265 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Plasma Radiofrequency Ablation at Low Temperature Versus Electrocautery Block Resection at High Frequency for Localized Recurrent Nasopharyngeal Carcinoma

Condition: Surgery · Recurrent Nasopharyngeal Carcinoma  ·  Sponsor: Sun Yat-sen University

PhaseNA
Planned participants500
Who can joinAll sexes, 18 Years to 70 Years
Healthy volunteersNo

About this study

This study aims at exploring whether plasma radiofrequency ablation at low temperature is associated with better survival outcome in localized recurrent nasopharyngeal carcinoma by conducting a randomized controlled trial of plasma radiofrequency ablation at low temperature versus electrocautery block resection at high frequency for localized recurrent nasopharyngeal carcinoma. If the hypothesis is confirmed, it is expected to provide a convenient choice for the surgical treatment of localized recurrent nasopharyngeal carcinoma.

This description comes directly from the study's public registry record.

Talk to the study team

Ming-Yuan Chen, MD, PhD  ·  86-20-8734-3361  ·  chmingy@mail.sysu.edu.cn

You-Ping Liu, MD, PhD  ·  86-13751763276  ·  liuyp78@mail.sysu.edu.cn

Always discuss trial participation with your own doctor first.

Locations (3)

Sun Yat-sen University Cancer CenterGuangzhou, Guangdong, ChinaRecruiting
The Fifth Affiliated Hospital of Sun Yat-sen UniversityZhuhai, Guangdong, ChinaRecruiting
The Nanchang Affiliated Hospital, Sun Yat-Sen University (Nanchang First Hospital)Nanchang, Jiangxi, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04425265